Zoetis Inc. Finance Lease, Liability, Noncurrent
Zoetis Inc. (ZTS) had Finance Lease, Liability, Noncurrent of $6.00 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2026-02-12
- 2025-12-31: Finance Lease, Liability, Noncurrent $6.00M.
- 2024-12-31: Finance Lease, Liability, Noncurrent $7.00M.
- 2023-12-31: Finance Lease, Liability, Noncurrent $8.00M.
- 2022-12-31: Finance Lease, Liability, Noncurrent $0.00.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2025-12-31 | $6.00M 10-K · filed 2026-02-12 |
| 2024-12-31 | $7.00M 10-K · filed 2026-02-12 |
| 2023-12-31 | $8.00M 10-K · filed 2025-02-13 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |